Quetiapine demonstrates good tolerability and is associated with improvements in extrapyramidal symptoms in patients with schizophrenia switched from other antipsychotics: results of a naturalistic study

By Hellewell Jonathan S. E.  

International Journal of Psychiatry in Clinical Practice, Vol. 11, Iss. 2, 2007-01 ,pp. : 112-122

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Efficacy and tolerability of quetiapine in poorly responsive, chronic schizophrenia

By Buckley P.F.   Goldstein J.M.   Emsley R.A.  

Schizophrenia Research, Vol. 66, Iss. 2, 2004-02 ,pp. : 143-150

Elsevier

Access to resources Recommend Favorite

The "Seroquel" Outcomes Study (SOS): Efficacy and tolerability of quetiapine in a long-term, naturalistic study of patients with schizophrenia

By Gibert Juan   Giner José   Bobes Julio   Tafalla Mónica   Herranz Santiago   Ovejero Carmen   Rico-Villademoros Fernando   GROUP for the SOS  

International Journal of Psychiatry in Clinical Practice, Vol. 11, Iss. 3, 2007-01 ,pp. : 222-232

Ashgate Publishing Ltd

Access to resources Recommend Favorite

An open multicentre pilot study examining the safety, efficacy and tolerability of fast titrated (800 mg/day by day 4) quetiapine in the treatment of schizophrenia/schizoaffective disorder

By Peuskens J.   Devoitille J. M.   Kusters J.   Vandenhoven G.  

International Journal of Psychiatry in Clinical Practice, Vol. 12, Iss. 4, 2008-01 ,pp. : 261-267

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Effects of amisulpride on the cognitive function of patients with schizophrenia who switched from risperidone

By Wang Yu-Ting   Chiu Nan-Ying   Jou Shaw-Hwa   Kuang Yang Yen   Hui Lee I   Wang Ching-Cheng   Ching Chen Kao   Liao Yi-Cheng  

International Journal of Psychiatry in Clinical Practice, Vol. 12, Iss. 3, 2008-01 ,pp. : 180-186

Ashgate Publishing Ltd

Access to resources Recommend Favorite